HilleVax (NASDAQ:HLVX - Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.33) by ($0.02), Zacks reports.
HilleVax Trading Down 8.8 %
Shares of NASDAQ:HLVX traded down $0.14 during trading on Monday, reaching $1.45. The company had a trading volume of 355,955 shares, compared to its average volume of 429,941. The company has a fifty day moving average of $1.82 and a two-hundred day moving average of $1.86. The stock has a market capitalization of $72.22 million, a P/E ratio of -0.47 and a beta of 0.76. HilleVax has a 12 month low of $1.42 and a 12 month high of $16.66.
Analyst Ratings Changes
Separately, HC Wainwright reissued a "neutral" rating and issued a $2.00 price target on shares of HilleVax in a report on Monday. Six analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $3.00.
Check Out Our Latest Research Report on HilleVax
About HilleVax
(
Get Free Report)
HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.
Further Reading
Before you consider HilleVax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HilleVax wasn't on the list.
While HilleVax currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
